#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Differential Contribution of PB1-F2 to the Virulence of Highly Pathogenic H5N1 Influenza A Virus in Mammalian and Avian Species


Highly pathogenic avian influenza A viruses (HPAIV) of the H5N1 subtype occasionally transmit from birds to humans and can cause severe systemic infections in both hosts. PB1-F2 is an alternative translation product of the viral PB1 segment that was initially characterized as a pro-apoptotic mitochondrial viral pathogenicity factor. A full-length PB1-F2 has been present in all human influenza pandemic virus isolates of the 20th century, but appears to be lost evolutionarily over time as the new virus establishes itself and circulates in the human host. In contrast, the open reading frame (ORF) for PB1-F2 is exceptionally well-conserved in avian influenza virus isolates. Here we perform a comparative study to show for the first time that PB1-F2 is a pathogenicity determinant for HPAIV (A/Viet Nam/1203/2004, VN1203 (H5N1)) in both mammals and birds. In a mammalian host, the rare N66S polymorphism in PB1-F2 that was previously described to be associated with high lethality of the 1918 influenza A virus showed increased replication and virulence of a recombinant VN1203 H5N1 virus, while deletion of the entire PB1-F2 ORF had negligible effects. Interestingly, the N66S substituted virus efficiently invades the CNS and replicates in the brain of Mx+/+ mice. In ducks deletion of PB1-F2 clearly resulted in delayed onset of clinical symptoms and systemic spreading of virus, while variations at position 66 played only a minor role in pathogenesis. These data implicate PB1-F2 as an important pathogenicity factor in ducks independent of sequence variations at position 66. Our data could explain why PB1-F2 is conserved in avian influenza virus isolates and only impacts pathogenicity in mammals when containing certain amino acid motifs such as the rare N66S polymorphism.


Vyšlo v časopise: Differential Contribution of PB1-F2 to the Virulence of Highly Pathogenic H5N1 Influenza A Virus in Mammalian and Avian Species. PLoS Pathog 7(8): e32767. doi:10.1371/journal.ppat.1002186
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002186

Souhrn

Highly pathogenic avian influenza A viruses (HPAIV) of the H5N1 subtype occasionally transmit from birds to humans and can cause severe systemic infections in both hosts. PB1-F2 is an alternative translation product of the viral PB1 segment that was initially characterized as a pro-apoptotic mitochondrial viral pathogenicity factor. A full-length PB1-F2 has been present in all human influenza pandemic virus isolates of the 20th century, but appears to be lost evolutionarily over time as the new virus establishes itself and circulates in the human host. In contrast, the open reading frame (ORF) for PB1-F2 is exceptionally well-conserved in avian influenza virus isolates. Here we perform a comparative study to show for the first time that PB1-F2 is a pathogenicity determinant for HPAIV (A/Viet Nam/1203/2004, VN1203 (H5N1)) in both mammals and birds. In a mammalian host, the rare N66S polymorphism in PB1-F2 that was previously described to be associated with high lethality of the 1918 influenza A virus showed increased replication and virulence of a recombinant VN1203 H5N1 virus, while deletion of the entire PB1-F2 ORF had negligible effects. Interestingly, the N66S substituted virus efficiently invades the CNS and replicates in the brain of Mx+/+ mice. In ducks deletion of PB1-F2 clearly resulted in delayed onset of clinical symptoms and systemic spreading of virus, while variations at position 66 played only a minor role in pathogenesis. These data implicate PB1-F2 as an important pathogenicity factor in ducks independent of sequence variations at position 66. Our data could explain why PB1-F2 is conserved in avian influenza virus isolates and only impacts pathogenicity in mammals when containing certain amino acid motifs such as the rare N66S polymorphism.


Zdroje

1. No authors listed 1997 Isolation of avian influenza A(H5N1) viruses from humans—Hong Kong, May-December 1997. MMWR Morb Mortal Wkly Rep 46 1204 1207

2. ShinyaKEbinaMYamadaSOnoMKasaiN 2006 Avian flu: influenza virus receptors in the human airway. Nature 440 435 436

3. YuenKYChanPKPeirisMTsangDNQueTL 1998 Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351 467 471

4. TranTHNguyenTLNguyenTDLuongTSPhamPM 2004 Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350 1179 1188

5. BeigelJHFarrarJHanAMHaydenFGHyerR 2005 Avian influenza A (H5N1) infection in humans. N Engl J Med 353 1374 1385

6. Abdel-GhafarANChotpitayasunondhTGaoZHaydenFGNguyenDH 2008 Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358 261 273

7. KortewegCGuJ 2008 Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 172 1155 1170

8. OlsenBMunsterVJWallenstenAWaldenstromJOsterhausAD 2006 Global patterns of influenza a virus in wild birds. Science 312 384 388

9. MunsterVJBaasCLexmondPWaldenstromJWallenstenA 2007 Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog 3 e61

10. WebsterRGYakhnoMHinshawVSBeanWJMurtiKG 1978 Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 84 268 278

11. KidaHYanagawaRMatsuokaY 1980 Duck influenza lacking evidence of disease signs and immune response. Infect Immun 30 547 553

12. PerkinsLESwayneDE 2003 Comparative susceptibility of selected avian and mammalian species to a Hong Kong-origin H5N1 high-pathogenicity avian influenza virus. Avian Dis 47 956 967

13. KimJKSeilerPForrestHLKhalenkovAMFranksJ 2008 Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J Virol 82 11374 11382

14. ChenWCalvoPAMalideDGibbsJSchubertU 2001 A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7 1306 1312

15. ChanturiyaANBasanezGSchubertUHenkleinPYewdellJW 2004 PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol 78 6304 6312

16. GibbsJSMalideDHornungFBenninkJRYewdellJW 2003 The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 77 7214 7224

17. YamadaHChounanRHigashiYKuriharaNKidoH 2004 Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 578 331 336

18. ZamarinDGarcia-SastreAXiaoXWangRPaleseP 2005 Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1 e4

19. VyssokikhMYBrdiczkaD 2003 The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim Pol 50 389 404

20. MazurIAnhlanDMitznerDWixlerLSchubertU 2008 The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10 1140 1152

21. McAuleyJLZhangKMcCullersJA 2010 The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 84 558 564

22. ConenelloGMZamarinDPerroneLATumpeyTPaleseP 2007 A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3 1414 1421

23. McAuleyJLChipukJEBoydKLVan De VeldeNGreenDR 2010 PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 6 e1001014

24. McAuleyJLHornungFBoydKLSmithAMMcKeonR 2007 Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2 240 249

25. ZellRKrumbholzAEitnerAKriegRHalbhuberKJ 2007 Prevalence of PB1-F2 of influenza A viruses. J Gen Virol 88 536 546

26. HaiRSchmolkeMVargaZTManicassamyBWangTT 2010 PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol 84 4442 4450

27. SteelJLowenACPenaLAngelMSolorzanoA 2009 Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 83 1742 1753

28. FranchiLAmerABody-MalapelMKannegantiTDOzorenN 2006 Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7 576 582

29. FranchiLEigenbrodTNunezG 2009 Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183 792 796

30. StaeheliPDreidingPHallerOLindenmannJ 1985 Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice. J Biol Chem 260 1821 1825

31. SolorzanoAWebbyRJLagerKMJankeBHGarcia-SastreA 2005 Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 79 7535 7543

32. MunsterVJSchrauwenEJde WitEvan den BrandJMBestebroerTM 2010 Insertion of a multibasic cleavage motif into the hemagglutinin of a low-pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype. J Virol 84 7953 7960

33. PenaLVincentALYeJCiacci-ZanellaJRAngelM 2011 Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol 85 456 469

34. LivakKJSchmittgenTD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402 408

35. HaleBGSteelJMedinaRAManicassamyBYeJ 2010 Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol 84 6909 6922

36. NemethAGuibertSTiwariVKOhlssonRLangstG 2008 Epigenetic regulation of TTF-I-mediated promoter-terminator interactions of rRNA genes. EMBO J 27 1255 1265

37. MarjukiHScholtissekCFranksJNegovetichNJAldridgeJR 2010 Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenza virus affect pathogenicity in mallard ducks. Arch Virol 155 925 934

38. TumpeyTMSzretterKJVan HoevenNKatzJMKochsG 2007 The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 81 10818 10821

39. ChenCJChenGWWangCHHuangCHWangYC 2010 Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol 84 10051 10062

40. ConenelloGMTisoncikJRRosenzweigEVargaZTPaleseP 2011 A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol 85 652 662

41. ShinyaKMakinoAHattaMWatanabeSKimJH 2011 Subclinical Brain Injury Caused by H5N1 Influenza Virus Infection. J Virol 85 5202 5207

42. ManicassamyBManicassamySBelicha-VillanuevaAPisanelliGPulendranB 2010 Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 107 11531 11536

43. WiseHMFoegleinASunJDaltonRMPatelS 2009 A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83 8021 8031

44. SalomonRFranksJGovorkovaEAIlyushinaNAYenHL 2006 The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med 203 689 697

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 8
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#